Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations
暂无分享,去创建一个
[1] M. Hendrix,et al. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. , 1999, Human molecular genetics.
[2] N. Ratner,et al. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells , 1998, Oncogene.
[3] Agnieszka Sidor,et al. NHE3 Kinase A Regulatory Protein E3KARP Binds the Epithelial Brush Border Na+/H+ Exchanger NHE3 and the Cytoskeletal Protein Ezrin* , 1998, Journal of Biological Chemistry.
[4] T. Jacks,et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. , 1998, Genes & development.
[5] S. Pulst,et al. Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin , 1998, Nature Genetics.
[6] T. Jacks,et al. Regulation of the Neurofibromatosis Type 2 Tumor Suppressor Protein, Merlin, by Adhesion and Growth Arrest Stimuli* , 1998, The Journal of Biological Chemistry.
[7] D. Gutmann,et al. Defects in neurofibromatosis 2 protein function can arise at multiple levels. , 1998, Human molecular genetics.
[8] K. Kaibuchi,et al. Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association , 1998, The Journal of cell biology.
[9] D. Gutmann,et al. Merlin differentially associates with the microtubule and actin cytoskeleton , 1998, Journal of neuroscience research.
[10] J. Gusella,et al. NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins* , 1998, The Journal of Biological Chemistry.
[11] D. Louis,et al. Universal absence of merlin, but not other ERM family members, in schwannomas. , 1997, The American journal of pathology.
[12] D. Gutmann,et al. Interdomain binding mediates tumor growth suppression by the NF2 gene product , 1997, Oncogene.
[13] A. Bretscher,et al. Identification of EBP50: A PDZ-containing Phosphoprotein that Associates with Members of the Ezrin-Radixin-Moesin Family , 1997, The Journal of cell biology.
[14] J. Jääskeläinen,et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. , 1997, Journal of cell science.
[15] P. Mangeat,et al. A Dual Involvement of the Amino-terminal Domain of Ezrin in F- and G-actin Binding* , 1997, The Journal of Biological Chemistry.
[16] P. Mangeat,et al. Three determinants in ezrin are responsible for cell extension activity. , 1997, Molecular biology of the cell.
[17] D. Gutmann,et al. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas , 1997, Neurology.
[18] D. Gutmann,et al. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules , 1997, Brain Research.
[19] S. Pulst,et al. Immunohistochemical Detection of Schwannomin and Neurofibromin in Vestibular Schwannomas, Ependymomas and Meningiomas , 1997, Journal of neuropathology and experimental neurology.
[20] Satoshi O. Suzuki,et al. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study , 1997, Acta Neuropathologica.
[21] V. Sundaram,et al. Reduced Expression of Schwannomin/Merlin in Human Sporadic Meningiomas , 1997 .
[22] J. Kimura,et al. Cyclin-dependent Kinase 5 in Lewy Body-like Inclusions in Anterior Horn Cells of a Patient with Sporadic Amyotrophic Lateral Sclerosis , 1997, Neurology.
[23] D. Gutmann,et al. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells , 1996, Journal of neuroscience research.
[24] T. Sasaki,et al. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway , 1996, The Journal of cell biology.
[25] J. Gusella,et al. The merlin tumor suppressor localizes preferentially in membrane ruffles. , 1996, Oncogene.
[26] S. Pulst,et al. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. , 1996, Oncogene.
[27] A. Bretscher,et al. Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis , 1995, The Journal of cell biology.
[28] T. H. van der Kwast,et al. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. , 1995, The American journal of pathology.
[29] F. Solomon,et al. Interdomain Interactions of Radixin in Vitro(*) , 1995, The Journal of Biological Chemistry.
[30] A. Bretscher,et al. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. , 1995, Molecular biology of the cell.
[31] G. Rouleau,et al. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. , 1995, Cancer research.
[32] F. Solomon,et al. Molecular dissection of radixin: distinct and interdependent functions of the amino- and carboxy-terminal domains , 1995, The Journal of cell biology.
[33] J. Gusella,et al. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). , 1994, The Journal of biological chemistry.
[34] N. Sato,et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.
[35] S. Pulst,et al. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. , 1994, Human molecular genetics.
[36] A. Bretscher,et al. Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Pulst,et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.
[38] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.
[39] E. R. Kandel,et al. Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication , 1993, Cell.
[40] R Eldridge,et al. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). , 1988, The New England journal of medicine.